Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 12/20 | 0.40 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14189776 | 1.00 | ALDH1A1 (0.56) | ALDH1A1ADRA1AL3MBTL3L3MBTL1SMN1; SMN2 | |
| SCHEMBL12449683 | 1.00 | ALDH1A1 (0.56) | ALDH1A1ADRA1AL3MBTL3L3MBTL1SMN1; SMN2 | |
| SCHEMBL26743234 | 0.96 | ALDH1A1 (0.53) | ALDH1A1ADRA1AL3MBTL3L3MBTL1SMN1; SMN2 | |
| SCHEMBL25855532 | 0.94 | ALDH1A1 (0.51) | ALDH1A1ADRA1AL3MBTL3L3MBTL1SMN1; SMN2 | |
| SCHEMBL27292954 | 0.90 | ALDH1A1 (0.46) | ALDH1A1ADRA1ASMN1; SMN2LMNA | |
| SCHEMBL22703922 | 0.87 | ALDH1A1 (0.46) | ALDH1A1ADRA1AL3MBTL3L3MBTL1SMN1; SMN2 | |
| SCHEMBL12717685 | 0.87 | ALDH1A1 (0.46) | ALDH1A1ADRA1AL3MBTL3L3MBTL1SMN1; SMN2 | |
| SCHEMBL20059837 | 0.87 | ALDH1A1 (0.46) | ALDH1A1ADRA1AL3MBTL3L3MBTL1SMN1; SMN2 | |
| SCHEMBL12718106 | 0.87 | ADRA1A (0.41) | ALDH1A1ADRA1ASMN1; SMN2LMNA | |
| SCHEMBL13036987 | 0.87 | ADRA1A (0.41) | ALDH1A1ADRA1ASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2499146-B1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO SA (CH) | 2016-09-21 | — | — | EP | disclosed |
| US-9073940-B2 | Tricyclic pyrazol amine derivatives | MERCK SERONO SA (CH) | 2015-07-07 | — | — | US | disclosed |
| US-9073940-B2 | Tricyclic pyrazol amine derivatives | MERCK SERONO SA (CH) | 2015-07-07 | — | — | US | disclosed |
| US-20120238545-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO SA (CH) | 2012-09-20 | — | — | US | disclosed |
| US-20120238545-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO SA (CH) | 2012-09-20 | — | — | US | disclosed |
| WO-2011058149-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO S.A. (CH) | 2011-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238545-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | PI4KB, MTOR, PI4KA | ALDH1A1 3185/4885ADRA1A 3308/4885L3MBTL3 4599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.